APA ציטוט

Khera, A. V., Millar, J. S., Ruotolo, G., Wang, M., & Rader, D. J. (2015). Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome. Eur Heart J.

Citação norma Chicago

Khera, Amit V., John S. Millar, Giacomo Ruotolo, Ming-Dauh Wang, and Daniel J. Rader. "Potent Peroxisome Proliferator-activated Receptor-α Agonist Treatment Increases Cholesterol Efflux Capacity in Humans With the Metabolic Syndrome." Eur Heart J 2015.

ציטוט MLA

Khera, Amit V., et al. "Potent Peroxisome Proliferator-activated Receptor-α Agonist Treatment Increases Cholesterol Efflux Capacity in Humans With the Metabolic Syndrome." Eur Heart J 2015.